Chad vs Nigeria: Hepatitis B surface antigen (HBsAg) prevalence
Chad
2.2%
in 2024
Nigeria
2.7%
in 2024
Chad rank
11th
Nigeria rank
8th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Chad
- Nigeria
How they compare
Nigeria currently reports 2.7% against 2.2% in Chad, a difference of 0.5%.
That makes Nigeria's figure about 1.2 times Chad's.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Chad ahead.
Chad ranks 11th and Nigeria ranks 8th of 194 countries.
Across the 2 decades both report, Chad averaged higher in 1 and Nigeria in 1.
Head to head by decade
| Decade | Chad | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.1% | 3.7% | 0.4% | Chad |
| 2020s | 3.0% | 3.1% | 0.1% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Chad or Nigeria?
- Nigeria, at 2.7% against 2.2% in Chad as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Chad and Nigeria?
- 0.5%, with Nigeria ahead.
- How many years of comparable data are there for Chad and Nigeria?
- 10 years are reported by both, from 2015 to 2024.
- How do Chad and Nigeria rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Chad ranks 11th and Nigeria ranks 8th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.